期刊文献+

叶酸修饰去甲斑蝥素隐形泡囊的制备、表征及体外药效学评价 被引量:4

Preparation,characterization and pharmacodynamic evaluation in vitro of norcantharidin-loaded folate-conjugated stealth niosomes
原文传递
导出
摘要 目的:制备叶酸修饰去甲斑蝥素隐形泡囊新型给药系统,并进行表征及体外药效学评价。方法:采用改良注入法制得新型给药系统,考察其形态、粒径、包封率和体外释放特性等理化性质对其进行表征,并通过它对叶酸受体过度表达Hela细胞的体外细胞摄取试验及生长抑制试验,进行体外药效学评价。结果:研制的隐形泡囊新型给药系统的平均粒径为100.87 nm,包封率为52.3%,体外释放显著缓慢于游离药物,且在模拟正常细胞pH 7.4环境下的释放t1/2是在模拟肿瘤细胞pH 5.0的1.98倍。细胞摄取试验说明叶酸泡囊能提高肿瘤细胞对药物的摄取(P<0.01)。细胞毒性试验证实,叶酸泡囊抑制肿瘤细胞生长的作用显著(P<0.01),但游离叶酸可减轻叶酸泡囊对肿瘤细胞的杀伤作用。结论:本研究采用简单易行的方法制得的叶酸修饰去甲斑蝥素隐形泡囊,体外具有pH敏感性、隐形性、叶酸受体靶向性,是一种具有良好开发前景的主动靶向抗肿瘤新型给药系统。 Objective: To prepare and characterize the novel drug delivery system, norcantharidin-loaded folate-eonjugated stealth niosomes, and to investigate their pharmacodynamic efficacy in vitro. Methods: The novel drug delivery system was prepared by modified injection method, and characterized by evaluation of their physical and chemical properties, such as appearance, particle size, entrapment rate, and in vitro release behavior. Phar- macodynamic evaluation was performed in vitro by cell uptake tests in Hela cells with overexpression of folate recep- tor and growth inhibition tests. Results: The average particle diameter of the norcantharidin-loaded folate-conjuga- ted stealth niosomes was 100.87 nm with an entrapment rate of 52.3%. The in vitro release was significantly slower than that of the free drug. The release t1/2 at pH 7.4 (simulated the normal cell environment) was 1.98 times as large as that at pH 5.0 (simulated cancer cell environment). Cell uptake tests indicated that they increased the cell uptake of cancer cells towards the drug (P 〈 0.01 ). Cytotoxicity tests demonstrated that they significantly in- hibited the growth of cancer cells (P 〈 0.01 ). However, the free folic acid decreased their lethal effect towards cancer cells. Conclusion: The norcantharidin-loaded folate-conjugated stealth niosomes have been prepared with simple and easy procedures. They show features of pH sensitivity, stealth and targeting effect towards folate recep-tor, providing a candidate of novel active targeting anticancer drug delivery system with good prospect.
机构地区 苏州大学药学院
出处 《中国新药杂志》 CAS CSCD 北大核心 2013年第18期2174-2178,共5页 Chinese Journal of New Drugs
基金 国家自然科学基金(81273462) 苏州大学自然基金预研项目(Q31320611) 苏州大学大学生创新实验计划项目(11cxxj068)
关键词 去甲斑蝥素 叶酸修饰隐形泡囊 理化性质 体外细胞试验 norcantharidin folate-conjugated stealth niosomes physical and chemical properties in vitrocell study
  • 相关文献

参考文献7

  • 1王广生 董成 等.去甲斑蝥素升高白细胞作用的研究[J].药学通报,1987,22(9):517-519. 被引量:8
  • 2HILL TA,STEWART SG,ACKLAND SP,et al.Norcantharimides synthesis and anticancer activity:synthesis of new norcantharidin analogues and their anticancer evaluation[J].Bioorg Med Chem,2007,15(18):6126-6134. 被引量:1
  • 3UCHEGBU IF,FLORENCE AT.Non-ionic surfactant vesicles (niosomes):physical and pharmaceutical chemistry[J].Advances Interface Sci,1995,58(1):1-55. 被引量:1
  • 4XIA W,LOW PS.Folate-targeted therapies for cancer[J].J Med Chem,2010,53(19):6811-6824. 被引量:1
  • 5王钦,成艳,张玮,张学农.去甲斑蝥素壳聚糖微球的制备及其体外释放特性[J].中国新药杂志,2008,17(11):947-951. 被引量:13
  • 6SADZUKA Y,NAKADE A,HIRAMA R,et al.Effects of mixed polyethyleneglycol modification on fixed aqueous layer thickness and antitumor activity of doxorubicin containing liposome[J].Int J Pharm,2002,238(1-2):171-180. 被引量:1
  • 7LEE ES,GAO Z,KIM D,et al.Super pH-sensitive multifunctional polymeric micelle for tumor pHe specificTAT exposure and multidrug resistance[J].J Control Release,2008,129(3):228-236. 被引量:1

二级参考文献11

共引文献19

同被引文献29

  • 1田少雷,赵树纬,朱爱堂,方茵,李克庆.抗肿瘤药物研究Ⅰ:去甲斑蝥素氨基酸衍生物的合成与抗癌活性[J].药学学报,1993,28(11):870-875. 被引量:6
  • 2杨玉柱,王储炎,焦必宁.叶酸的研究进展[J].农产品加工(下),2006(5):31-35. 被引量:49
  • 3王爽,梁伟伶,刘斯斯,尹继云,徐馨,秦学功.正交试验法优选HepG2细胞最佳培养条件[J].中国现代医学杂志,2007,17(13):1603-1605. 被引量:4
  • 4Wei C M,Teng Y N,Wang B J,et al.Separation and identification of norcantharidin metabolites in vivo by GC-MS method[J].J Chromatogr B,2011,879(4):1741- 1747. 被引量:1
  • 5Brandon E F,Raap C D,Meijerman I,et al.An update on invitro test methods in human hepatic drug biotransformation research:pros and cons[J].Toxicol Appl Pharmacol,2003,189(3):233-246. 被引量:1
  • 6Clinical and Laboratory Standards Institute.Evaluation of Precision Performance of Quantitative Measurement Methods;Approved Guideline-Second Edition[S].EP5-A2,CLSI,2004. 被引量:1
  • 7Clinical and Laboratory Standards Institute.EP15-A2 User Verification of Performance for Precision and Trueness;Approved Guideline-Second Edition[S].2005. 被引量:1
  • 8Clinical and Laboratory Standards Institute.EP7-A2 Interference Testing in Clinical Chemistry;Approved Guideline-Second Edition[S].2005. 被引量:1
  • 9Garde AH,Hansen AM,Skovgaard LT,et al.Seasonal and biological variation of blood concentrations of total cholesterol,dehydroepiandrosterone sulfate,hemoglobin A1C,IgA,prolactin and free testosterone in healthy women[J].Clin Chem,2000,46(4):551. 被引量:1
  • 10Clinical and Laboratory Standards Institute.EP6-A Evaluation of the Linearity of Quantitative Measurement Procedures;A Statistical Approach;Approved Guideline[S].2003. 被引量:1

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部